Collagen-induced platelet aggregation is largely dependent on ADP in man and entirely dependent on ADP in rats, with TxB2 formation likely dependent on prior ADP release or aggregation.
Answers are grounded in this paper and cite their sources.
Species differences limit rat-to-human extrapolation for aspirin; leaves open ADP-independent pathways in human aggregation.
The effects of aspirin, carboxyheptylimidazole (CHI) and creatine phosphate/creatine phosphokinase (CP/CPK) on platelet aggregation and thromboxane B2 (TxB2) formation induced by collagen have been examined in vitro. Platelets from two species, man and the rat, have been used. In man, aspirin and CHI abolished TxB2 production but only partially inhibited aggregation. CP/CPK partially inhibited aggregation and TxB2 formation. In the rat, aspirin and CHI abolished TxB2 formation but had no effect on aggregation. CP/CPK completely inhibited aggregation and partially inhibited TxB2 generation. In man, collagen-induced aggregation is largely dependent on ADP and to a lesser extent on arachidonate metabolites whereas, in the rat, ADP alone mediates aggregation induced by this agonist. The results with CP/CPK suggest that TxB2 formation is dependent either on the prior release of platelet ADP or on aggregation itself rather than being responsible for the aggregation response.
No takes yet. Share an insight, caveat, or question.
Emms et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: